spacer
home > epc > Spring 2016
PUBLICATIONS

European Pharmaceutical Contractor

epc
Spring 2016

   
Text
PDF
bullet
Marketplace & Business
Pricing and Market Access

People Skills


According to a-connect's Aunia Grogan and Claire Hempshall, it is vital to establish and maintain access to drugs in an evolving environment, which is characterised by tight budgets, shifting market trends and new therapy areas, among others.


 
view
download pdf
bullet
Marketplace & Business: Translation Feature
Translation Tools

Lingua Franca


Translation technology has grown in conjunction with the increasing number of clinical trials carried out globally. Trevor Korb at Corporate Translations wonders how these new tools can aid pharma.

 
view
download pdf
bullet
Legal & Regulatory
Clinical Evaluation

Conform to the Norm: Part 2


Continuing from EPC February, Terry Winchell at GCP Innovative Dynamics further elaborates on current regulations concerning clinical investigator disqualifications, and shares practical advice.

 
view
download pdf
bullet
Electronic Solutions
Patient Communication Technology

Talk Technical


Dr Mark Hooper at Conversis Medical Translations observes how technology has an impact on nearly all areas in the pharma industry, and that patient adherence, communication, enrolment and retention can be improved as a result.

 
view
download pdf

Medical Writing
Medical Writing Metrics

Do You Measure Up?


There is a pressing need to measure the performance of service providers for evaluation purposes, states Trilogy Writing & Consulting’s Dr Julia Forjanic Klapproth, while emphasising that metrics for medical writing are not simple to establish.

 
view
download pdf

Interview
Q&A: Electronic Patient-Reported Outcomes

Digital Approach

John Sage
at iCardiac tells EPC about the increasing demand for ePRO technologies, which opens up significant growth opportunities for developers of such innovations.

 
view
download pdf
   
spacer



Published quarterly in
February, May,
August, and November

News and Press Releases

3P Biopharmaceuticals and Nordic Nanovector have extended partnership for Betalutin® late stage manufacturing for B-cell non-Hodgkin lymphoma (NHL) treatment

The non-Hodgkin lymphoma (NHL) is a cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system
More info >>

White Papers

Modifying MDI Canister Surfaces to Improve Drug Stability & Drug Delivery

Presspart Manufacturing Ltd

Hydrofluoroalkane (HFA)-based propellants are widely used in modern metered-dose inhalers (MDIs), due to their lack hazardous and environmentally-damaging effects. However, an HFA's active pharmaceutical ingredient can interact with the canister substrate, causing deposition of the drug to the canister walls, or interact with the solution, causing degradation and resulting in increased impurity levels. Over the past few years, a number of surface coatings have been developed that can be applied to MDI canisters and valve components, to protect the contents from deposition and degradation. More recently, plasma processes have been developed to modify and improve the surface energy performance of a MDI canister. This approach has a number of advantages to alternative coatings but requires careful optimisation to ensure the highest quality finish and MDI performance. Richard Turner, Business Development Director, Presspart Manufacturing Ltd, explains.
More info >>

Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement